RET inhibition: implications in cancer therapy

Author： Borrello Maria Grazia   Ardini Elena   Locati Laura D   Greco Angela   Licitra Lisa   Pierotti Marco A  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.4, 2013-04, pp. : 403-419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of RET Kinase Inhibitors for Targeted Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 162-175

Bentham Science Publishers

Access to resources Recommend Favorite

Bortezomib: Proteasome Inhibition as a Novel Mechanism of Cancer Therapy-Implications for Hematological Malignancies

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 2, 2007-03 ,pp. : 82-86

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy

By O'Regan Ruth   Hawk Natalyn Nicole  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 859-872

Informa Healthcare

Access to resources Recommend Favorite

Selective Raf inhibition in cancer therapy

By Khazak Vladimir   Astsaturov Igor   Serebriiskii Ilya G   Golemis Erica A  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1587-1609

Informa Healthcare

Access to resources Recommend Favorite

TGF Beta Inhibition for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 6, Iss. 7, 2006-11 ,pp. : 565-578

Bentham Science Publishers

Access to resources Recommend Favorite